The global DNA sequencing services market is anticipated to be valued at USD 945.6 million in 2023. The market is forecast to expand at a CAGR of 8.2% from 2023 to 2033, valued at USD 2,080.2 million by 2033. Growth is attributed to the increase in cancer cases around the world.
DNA sequencing determines the sequence of the four DNA bases: adenine, thymine, guanine, and cytosine. Adenine (A) always pairs with thymine (T); cytosine (C) always pairs with guanine (G). The sequencing of the DNA base pairs is important to establish the genetic information to be used further in determining regulatory instructions, gene positioning, and others.
| Data Points | Key Statistics |
|---|---|
| Growth Rate (2018 to 2022) | USD 6.7% CAGR |
| Expected Market Value (2023) | USD 945.6 million |
| Anticipated Forecast Value (2033) | USD 2,080.2 million |
| Projected Growth Rate (2023 to 2033) | 8.2% CAGR |
DNA sequencing has been used as an important tool in diagnosing chronic diseases as it highlights changes in the gene that causes disease. During the time of cell division, the base pairs are copied, and this is the fact that most of the experiments are carried out on the DNA bases.
Rapid advancements in sequencing technology and bioinformatics have enabled the identification of DNA variations, which are expected to boost the growth of the DNA sequencing services industry during the forecast period.
On the other hand, ethical and legal limitation associated with NGS is one of the crucial factors expected to hamper the growth of the DNA sequencing services industry over the analysis period.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Factors such as the increase in cancer cases around the world, rising research studies, increasing collaborations between research institutes and market players, as well as rising applications of DNA next-generation sequencing and technological advancements in sequencing technologies, are all expected to accelerate the growth of the DNA sequencing services industry over the analysis period.
The need for DNA sequencing methods is expected to expand as research and development activities for treatments to treat genetic disorders increase. Substantial market demand may be created as research and development investments increase and studies related to treating genetic disorders among individuals grow.
Governments in industrialized economies have implemented programs and laws to encourage scientists and researchers to explore treatments for chronic and rare diseases.
Hospitals choose DNA sequencing techniques because they can deliver clinical diagnosis in less time, which helps the market grow. In addition, DNA sequencing can be utilized to collect the most up-to-date data and identify transmission links to avoid infections across hospital settings. All these factors are expected to propel the growth of the DNA sequencing services industry during the forecast period.
The need for more skilled professionals is a key factor expected to hamper the growth of the DNA sequencing services market during the forecast period. Additionally, ethical and legal limitation associated with NGS is another key factor expected to impede the market growth over the analysis period.
Principal Consultant
| Region | North America |
|---|---|
| Market Share % (2022) | 40.6% |
Regarding regional platforms, North America holds a significant market share in DNA sequencing services industry.
North America is the biggest DNA sequencing services industry market, attributed to several clinical laboratories that use NGS to offer genetic testing services, which drives the regional market.
| Region | Europe |
|---|---|
| Market Share % (2022) | 32.4% |
According to Future Market Insights, Europe is expected to provide immense growth opportunities for DNA sequencing services and reach a significant share of more than 32.4% in 2023.
The DNA sequencing services market in Europe is expected to witness significant market growth, owing to many prominent market players in the region.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Prominent market players in the DNA sequencing services industry are working hand-in-hand to provide the best-in-class DNA sequencing services for enhancing the global genetics arena.
However, many global start-ups in the DNA sequencing services market are stepping forward to match the requirements of the DNA sequencing services domain.
Some key participants present in the global DNA sequencing services market include Illumina Inc., Thermo Fischer Scientific Inc., Oxford Nanopore Technologies Plc, Agilent Technologies, Inc., QIAGEN, Eurofins Scientific, F. Hoffmann-La Roche Ltd., Takara Bio Inc., GENEWIZ, Inc., Hamilton Company, Macrogen Inc., Zymo Research Corporation, and Tecan Trading AG, among others.
Due to the presence of several leading participants, the market is highly competitive. Global players such as Illumina Inc., Thermo Fischer Scientific Inc., and Oxford Nanopore Technologies plc. Account for a considerable market size, several regional-level players are also operating across key growth regions, particularly in North America.
Recent Developments
| Attribute | Details |
|---|---|
| Growth Rate | CAGR of 8.2% from 2023 to 2033 |
| Market Value in 2023 | USD 945.6 million |
| Market Value in 2033 | USD 2,080.2 million |
| Base Year for Estimation | 2022 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in USD million, and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Product Type, End Use, Application, Region |
| Regions Covered | North America; Latin America; Europe; Asia Pacific; The Middle East and Africa |
| Key Countries Profiled | The United States, Canada, Brazil, Mexico, Germany, The United Kingdom, France, Spain, Italy, China, Japan, South Korea, India, Malaysia, Singapore, Australia, New Zealand, GCC, South Africa, Israel |
| Key Companies Profiled | Thermo Fisher Scientific Inc.; Abbott Laboratories; GE Healthcare; Merck KGaA; Agilent Technologies Inc.; Roche Holdings AG; Pacific Biosciences; Illumina Inc.; Bio-Rad Laboratories Inc. |
| Customization | Available Upon Request |
The market is estimated to secure a valuation of USD 945.6 million in 2023.
The market is forecast to register a CAGR of 8.2% through 2033.
The market expanded at a CAGR of 6.7%
Advances in sequencing and bioinformatics DNA variations are the top trend.
The global market size is estimated to reach USD 2,080.2 million by 2033.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Maxam–Gilbert DNA Sequencing 5.2. Chain-Termination Methods 5.3. Dye-Terminator Sequencing 5.4. Automation and Sample Preparation 5.5. Large-Scale DNA Sequencing 5.6. New DNA Sequencing Methods 5.7. High Throughput DNA Sequencing 5.8. Parallel Signature Sequencing (MPSS) 5.9. Polony Sequencing 5.10. Pyrosequencing 5.11. SOLiD Sequencing 5.12. Others 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 6.1. Clinical Investigation 6.2. Oncology 6.3. Forensics & Agrigenomics 6.4. Reproductive Health 6.5. HLA Typing 6.6. Others 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-Use 7.1. Clinical Research 7.2. Academic Research 7.3. Biotechnology & Pharmaceutical Companies 7.4. Hospitals & Clinics 7.5. Others 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. North America 8.2. Latin America 8.3. Western Europe 8.4. Eastern Europe 8.5. South Asia and Pacific 8.6. East Asia 8.7. Middle East and Africa 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. Key Countries Market Analysis 17. Market Structure Analysis 18. Competition Analysis 18.1. Thermo Fisher Scientific Inc. 18.2. Abbott Laboratories 18.3. GE Healthcare 18.4. Merck KGaA 18.5. Agilent Technologies Inc. 18.6. Roche Holdings AG 18.7. Pacific Biosciences 18.8. Illumina Inc. 18.9. Bio-Rad Laboratories Inc. 18.10. Myriad Genetics 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
DNA Sequencing Services Market
